Table 3.
Five-Year EFS and OS by Treatment Group and Disease Characteristics for Eligible Patients
| Characteristic | 5-Year EFS |
5-Year OS |
||||
|---|---|---|---|---|---|---|
| Rate (%) | SE (%) | P | Rate (%) | SE (%) | P | |
| Sex | .96 | .90 | ||||
| Male | 68.6 | 4.1 | 73.7 | 3.9 | ||
| Female | 67.3 | 4.9 | 75.9 | 4.5 | ||
| Race | .75 | .48 | ||||
| White | 69.3 | 3.6 | 75.7 | 3.3 | ||
| Black | 61.0 | 8.5 | 66.6 | 8.3 | ||
| Hispanic | 75.0 | 12.5 | 82.5 | 11.3 | ||
| Other | 57.1 | 18.7 | 71.4 | 17.1 | ||
| Randomly assigned regimen | .54 | .47 | ||||
| CT1 | 66.0 | 4.5 | 73.1 | 4.2 | ||
| RT1 | 70.0 | 4.4 | 76.1 | 4.1 | ||
| M stage | < .001* | < .001* | ||||
| M0 | 74.0 | 4.1 | 81.6 | 3.6 | ||
| M1 | 64.9 | 9.0 | 68.3 | 8.8 | ||
| M2 | 69.2 | 7.7 | 77.6 | 7.0 | ||
| M3 | 61.6 | 8.4 | 64.5 | 8.3 | ||
| M4 | 22.2 | 13.9 | 33.3 | 15.7 | ||
| M+ (M1, M2, M3, or M4) | 61.6 | 4.7 | 67.1 | 4.6 | ||
Abbreviations: CT1, chemotherapy first; EFS, event-free survival; OS, overall survival; RT1, radiation therapy first.
*
Log-rank P value in comparing M4 v others (M0, M1, M2, or M3).